Unknown

Dataset Information

0

Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's disease.

ABSTRACT: Early Huntington's disease (HD) include over-activation of dopamine D1 receptors (D1R), producing an imbalance in dopaminergic neurotransmission and cell death. To reduce D1R over-activation, we present a strategy based on targeting complexes of D1R and histamine H3 receptors (H3R). Using an HD mouse striatal cell model and HD mouse organotypic brain slices we found that D1R-induced cell death signaling and neuronal degeneration, are mitigated by an H3R antagonist. We demonstrate that the D1R-H3R heteromer is expressed in HD mice at early but not late stages of HD, correlating with HD progression. In accordance, we found this target expressed in human control subjects and low-grade HD patients. Finally, treatment of HD mice with an H3R antagonist prevented cognitive and motor learning deficits and the loss of heteromer expression. Taken together, our results indicate that D1R - H3R heteromers play a pivotal role in dopamine signaling and represent novel targets for treating HD.

SUBMITTER: Moreno-Delgado D 

PROVIDER: S-EPMC7282811 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Early Huntington's disease (HD) include over-activation of dopamine D<sub>1</sub> receptors (D<sub>1</sub>R), producing an imbalance in dopaminergic neurotransmission and cell death. To reduce D<sub>1</sub>R over-activation, we present a strategy based on targeting complexes of D<sub>1</sub>R and histamine H<sub>3</sub> receptors (H<sub>3</sub>R). Using an HD mouse striatal cell model and HD mouse organotypic brain slices we found that D<sub>1</sub>R-induced cell death signaling and neuronal deg  ...[more]

Similar Datasets

Unknown Marked changes in signal transduction upon heteromerization of dopamine D1 and histamine H3 receptors.
| S-EPMC2697789 | biostudies-literature
Unknown Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms.
| S-EPMC3948077 | biostudies-literature
Unknown Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway.
| S-EPMC3037697 | biostudies-literature
Unknown Inhibitory effects of dopamine on spinal synaptic transmission via dopamine D1-like receptors in neonatal rats.
| S-EPMC3417505 | biostudies-literature
Unknown Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors?
| S-EPMC2849918 | biostudies-literature
Unknown Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPase.
| S-EPMC2605984 | biostudies-literature
Unknown The Functional Vision Protection Effect of Danshensu via Dopamine D1 Receptors: In Vivo Study.
| S-EPMC8002943 | biostudies-literature
Unknown Modulation of nuclear REST by alternative splicing: a potential therapeutic target for Huntington's disease.
| S-EPMC5661251 | biostudies-literature
Unknown Thrombospondin1 mimics rapidly relieve depression via Shank3 dependent uncoupling between dopamine D1 and D2 receptors.
| S-EPMC10119609 | biostudies-literature
Unknown Modulation of appetitive motivation by prefrontal cortical mu-opioid receptors is dependent upon local dopamine D1 receptor signaling.
| S-EPMC8330959 | biostudies-literature